Medtronic recalls a second directional atherectomy device due to risk of tip damage

Michael Walter | | Cardiovascular Business | Vascular & Endovascular
Product Recall

Medtronic has announced a voluntary recall of its 6 French TurboHawk Plus Directional Atherectomy System, an interventional solution designed to remove blockages in a patient’s legs. The recall is related to potential issues with the catheter’s guidewire moving or prolapsing during use, which can lead to adverse events.

Medtronic emphasized that there have been no reports of incidents with this device. The company recently recalled its HawkOne Directional Atherectomy System due to the risk of prolapse, however, and has now decided to recall the TurboHawk system due to similarities between the two devises.

Approximately 800 devices are included in this latest recall. Medtronic has told both patients and clinicians that no actions need to be taken—the company is not retrieving impacted devices. Instead, Medtronic aims to “reiterate the existing warnings and precautions” included in the TurboHawk system’s instructions that detail the risk of tip damage caused by guidewire prolapse.

“Physicians should continue to monitor patients in accordance with their medical facility’s standard care protocols,” the company said in a statement.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."